logo-loader
viewKopin Corporation

Kopin Corp's smart glasses to be showcased at IRONMAN events

The new hi-tech glasses will be showcased at the IRONMAN World Championship, the group said

1532108327_solos-glasses.jpg
Kopin said the glasses allow triathletes, cyclists and runners to receive critical information

Kopin Corp (NASDAQ:KOPN) revealed that its SOLOS unit has struck a partnership deal for its Smart Glasses with IRONMAN, which famously operates a global portfolio of events that includes the triathlon series.

The new hi-tech glasses will be showcased at the IRONMAN World Championship and various other events in the US and Canada throughout this year, starting at IRONMAN Lake Placid on July 22.

READ: Kopin unveils world's smallest smart glass display

SOLOS is the world’s lightest augmented reality (AR) smart glasses for sports performance.

Kopin said the glasses allow triathletes, cyclists and runners to receive critical information from sight and sound about their performance.

“We know IRONMAN athletes are always looking for quality, ingenuity and as much valuable data as possible in the devices they wear,” said Stuart Selig, EVP of Global Partnerships at IRONMAN.

“SOLOS smart glasses provide just that — an innovative product that will empower them to achieve optimal performance. We believe this partnership offers our athletes a unique training advantage across North America."

“We’re thrilled to announce our partnership with IRONMAN,” added Scott Fliegelman, the director of strategic partnerships for SOLOS.

"As a 5-time IRONMAN, I’m personally excited to share our amazing technology with today’s athletes, who are looking for improved performance, safety and fun.”

Quick facts: Kopin Corporation

Price: 0.37 USD

NASDAQ:KOPN
Market: NASDAQ
Market Cap: $31.42 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CytoDyn's therapy used to treat New York coronavirus...

CytoDyn Inc (OTCMKTS:CYDY) CEO Nader Pourhassan tells Proactive the biotech shared positive test results today from seven coronavirus (COVID-19) patients who were treated with the company’s drug leronlimab at a leading medical center in the New York City area. Pourhassan, together diagnostics...

2 days, 10 hours ago

2 min read